Hall C L
Br Med J. 1974 Oct 5;4(5935):15-6. doi: 10.1136/bmj.4.5935.15.
Ninety-four patients receiving immunosuppressive therapy with azathioprine and prednisone after human cadaver kidney transplantation developed urinary tract infections and were treated with co-trimoxazole or another antibiotic in a controlled randomized prospective trial. The incidence of leucopenia in the group treated with co-trimoxazole (10.6%) was not significantly different from that in the group treated with other antibiotics (23.6%). Leucopenia when it occurred did so soon after transplantation at a time when the function of the renal transplant was poor in relation to the dosage of azathioprine given. In all cases the temporary withdrawal of azathioprine relieved the leucopenia despite continuation of the co-trimoxazole treatment. This study did not provide any evidence that co-trimoxazole plus azathioprine was a more potent cause of leucopenia than azathioprine alone.
在一项对照随机前瞻性试验中,94例接受人尸体肾移植后使用硫唑嘌呤和泼尼松进行免疫抑制治疗的患者发生了尿路感染,并接受了复方新诺明或其他抗生素治疗。接受复方新诺明治疗的组中白细胞减少症的发生率(10.6%)与接受其他抗生素治疗的组(23.6%)相比无显著差异。白细胞减少症发生在移植后不久,此时肾移植功能相对于所给予的硫唑嘌呤剂量较差。在所有病例中,尽管继续使用复方新诺明治疗,但暂时停用硫唑嘌呤可缓解白细胞减少症。这项研究没有提供任何证据表明复方新诺明加硫唑嘌呤比单独使用硫唑嘌呤更易导致白细胞减少症。